版本:
中国

BRIEF-Scynexis says to present SCY-078 data on lead anti-infective candidate

April 12 Scynexis Inc

* Scynexis inc says to present scy-078 data on novel lead anti-infective candidate

* Scynexis inc says oral presentation of phase 2 study discusses oral scy-078 in patients with invasive candidiasis

* Scynexis inc says potent in vitro activity of scy-078 against multidrug-resistant fungal pathogen candida auris Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐